Bevatas 100 mg injection
  1. Home
  2. Pharma Products
  3. Intas Pharmaceuticals Ltd
  4. Bevatas 100 mg injection

Bevatas 100 mg injection

Bevatas 100 mg Injection contains bevacizumab 100 mg and is a targeted anticancer medicine. It is used for several advanced cancers, including colorectal, breast, lung, kidney, ovarian, and cervical cancers. The medicine is administered as an intravenous infusion by a qualified healthcare professional.

BUY NOW

Category

Bevacizumab is a monoclonal antibody that targets VEGF and helps inhibit the formation of new blood vessels that supply tumors. It is commonly used with chemotherapy or other anticancer medicines according to the specific cancer and treatment protocol. Blood pressure, urine protein, wound healing, and other clinical parameters may require monitoring because treatment can cause hypertension, proteinuria, bleeding, and other adverse effects. The dosage and infusion schedule are determined by the treating oncologist based on the cancer type and individual treatment plan.

Technical Specification

Specification Details
Active Ingredient Bevacizumab
Strength 100 mg/4 mL
Dosage Form Solution for Infusion
Route of Administration Intravenous Infusion
Pack Size 1 vial of 4 mL
Manufacturer Intas Pharmaceuticals Ltd

Product Also Known As

Bevatas 100mg Injection, Bevatas 100 mg Injection, Bevacizumab 100mg Injection, Bevacizumab 100 mg Injection, Bevacizumab 100mg Infusion, Bevacizumab 100mg Oncology Injection